News & Stories
2022
News
HKUST & HKUMed Joint Study Reports Broadly Neutralizing Antibody That Protects Syrian Hamsters against SARS-CoV-2 Omicron Variants
Structural biologists at The Hong Kong University of Science and Technology (HKUST) together with researchers at the AIDS Institute, The University of Hong Kong (HKU), Department of Microbiology, School of Clinical Medicine, the LKS Faculty of Medicine of The University of Hong Kong (HKUMed) and the State Key Laboratory of Emerging Infectious Diseases, HKU have demonstrated that ZCB11, a broadly neutralising antibody derived from a local mRNA-vaccinee against the spreading Omicron variants of SARS-CoV-2, displays potent antiviral activities against all variants of concern (VOCs), including the dominantly spreading Omicron BA.1, BA1.1 and BA.2. Critically, either prophylactic or therapeutic ZCB11 administration protects lung infection against Omicron viral challenge in golden Syrian hamsters.
Stories
It’s a Numbers Game
I was quite a bad student until I found my passion.Having dreamed of working in the gaming industry from a young age, Prof. Kenneth LEUNG, Assistant Professor of Engineering Education at HKUST’s School of Engineering never thought he would become a professor one day, let alone winning a teaching award. “I was quite a bad student until I went to college,” recounts the winner of the HKUST 2021 Common Core Teaching Excellence Award. “But then I discovered an interest in computer science and continued my studies in the graduate level. Before I realized, I became a teaching assistant (TA), and now, a professor at HKUST where I got my PhD.” Expectations met Reality